<DOC>
	<DOCNO>NCT01311765</DOCNO>
	<brief_summary>The investigator purpose demonstrate short antibiotic therapy ( 8 day ) postoperative peritonitis brings increase number antibiotic-free day 28 day period compare conventional ( 15 day ) treatment .</brief_summary>
	<brief_title>Duration Antibiotic Therapy Treatment Severe Postoperative Peritonitis Admitted ICU</brief_title>
	<detailed_description>This prospective randomize study involve 25 center . Our goal demonstrate course postoperative peritonitis short antibiotic therapy ( 8 day ) compare conventional antibiotic treatment ( 15 day ) decrease duration exposure antibiotic 28 day period . Patients admit ICU , operate postoperative peritonitis receive adequate antibiotic therapy identify informed consent obtain randomized receive short course antibiotic therapy ( 8 day ) long course antibiotic therapy ( 15 day ) . The primary endpoint number antibiotic-free day D28 inclusion ( analysis superiority ) . Secondary endpoint include mortality D45 inclusion ( analysis equivalence ) , occurrence relapse infection , success rate clinically microbiologically evaluable patient , emergence multidrug resistant microorganisms clinical isolates hygiene sample . Patient data day 45 follow initial intervention hospital discharge track .</detailed_description>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>The eligible patient fulfill follow criterion 1. patient admit intensive care unit 2. 24 hour follow surgery postoperative intraabdominal infection ( define gross pu purulent effusion within peritoneal cavity one several collection ) . Postoperative infection define infection observe delay 60 day follow procedure ( endoscopy , surgery ( abdominal , urologic , gynecologic vascular surgery surgery perform peritoneal retroperitoneal space ) interventional radiology ) 3. peroperative microbiologic sample collect 4. receive empiric antibiotic therapy initiate within first 24 hour completion surgery 5. write informed consent patient relative legal representative emergency consent Noninclusion criterion : Patients one follow criterion eligible study : 1. age &lt; 18 2. pregnancy 3 . Duration stay follow inclusion &lt; 72 hour 4. neutropenia ( PMN &lt; 500/mm3 ) due chemotherapy hematological disease 5 . AIDS stage C 6 . Immunosuppressive therapy prolong steroid therapy ( â‰¥0.5 mg/kg/d prednisone equivalent &gt; 1 month 7 . Bowel perforation follow endoscopy treat delay &lt; 6 hour injury 8 . Uterine perforation follow surgical procedure treat delay &lt; 6 hour injury 9 . Moribund patient ( SAPS II score &gt; 65 within 12 hour precede inclusion ) 10 . Limitation treatment previously decide 11 . Surgery consider non curative surgeon 12 . Patient include another clinical trial evaluate antimicrobial agent Secondary exclusion criterion : Among eligible patient , one follow criterion exclude 1 . Negative culture peritoneal fluid 2 . Peritoneal culture exclusively fungal 3 . Inadequate empiric antibiotic therapy ( target microorganism culture peritoneal blood culture ) within 24 hour surgery 4 . Death D1 D8</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Postoperative peritonitis</keyword>
	<keyword>Intra-abdominal infection</keyword>
	<keyword>Surgery</keyword>
	<keyword>Laparotomy</keyword>
	<keyword>Nosocomial infection</keyword>
	<keyword>Antibiotic therapy</keyword>
	<keyword>Duration treatment</keyword>
	<keyword>Multidrug resistant bacteria</keyword>
</DOC>